Search for: "Novell, Inc." Results 121 - 140 of 2,793
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jul 2023, 1:30 pm by Satya Marar
In other words, the vertical merger would fuse two firms that don’t compete head-to-head, forging a more powerful entity that can efficiently leverage the products of one firm with the resources and greater access to novel markets of the other. [read post]
17 Jul 2023, 9:05 pm by ilyabeylin
Last Thursday’s split summary-judgment decision in the case that the Securities and Exchange Commission (SEC) brought against Ripple Labs, Inc. [read post]
17 Jul 2023, 8:32 am by Eric Goldman
Abitron garnered far less attention than did other intellectual property (IP) cases argued this term, including Jack Daniels Products, Inc. v. [read post]
14 Jul 2023, 10:21 am by Zak Gowen
The novel funding approach allows the agency to ignore states’ concerns and their traditional oversight role, according to the brief. . . . [read post]
7 Jul 2023, 10:18 am by Daily Record Staff
Novavax, Inc., a Gaithersburg-based, global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has been granted full marketing authorization by the European Commission in the European Union (EU) for its COVID vaccine Nuvaxovid. [read post]
6 Jul 2023, 11:34 am by Unknown
District Court of the Southern District of New York, the digital asset exchange Coinbase Inc. weighed in with a point-by-point response to the SEC complaint filed June 6 and asked the court to dismiss the SEC’s charges with prejudice. [read post]
21 Jun 2023, 4:27 am by Andrew Lavoott Bluestone
Tueme v Lezama 2023 NY Slip Op 03036 Decided on June 7, 2023 Appellate Division, Second Department is practically a gothic novel, with allegations of false testimony, false accusations and perjured testimony all in aid of getting a better divorce settlement. [read post]
20 Jun 2023, 5:55 am by Jennifer Papapanagiotou
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
14 Jun 2023, 6:31 am
Securities and Exchange Commission (the “SEC” or the “Commission”) has had a busy start to its Fiscal Year 2023 enforcement program, continuing its vigorous approach to enforcement with its use of novel theories and enhanced remedies. [read post]
14 Jun 2023, 6:31 am
Securities and Exchange Commission (the “SEC” or the “Commission”) has had a busy start to its Fiscal Year 2023 enforcement program, continuing its vigorous approach to enforcement with its use of novel theories and enhanced remedies. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
8 Jun 2023, 10:22 am by Samar Shah
Teleflex Inc., 550 U.S. 398 (2007), which established a new ordinary innovation standard]. [read post]